Focà, Emanuele http://orcid.org/0000-0003-4395-5379
Fornari, Chiara
Arsuffi, Stefania
Vetrano, Maria Chiara
Calza, Stefano
Renzetti, Stefano
Copeta, Silvia
Berruti, Alfredo
Castelli, Francesco
Compostella, Silvia
Quiros-Roldan, Eugenia
Funding for this research was provided by:
Gilead Sciences
Università degli Studi di Brescia
Article History
Accepted: 18 February 2022
First Online: 6 March 2022
Change Date: 22 July 2022
Change Type: Update
Change Details: Open access funding note has been updated
Declarations
:
: EF received speakers’ honoraria, research grants and advisory board fees from Viiv Healthcare, Janssen-Cilag, Gilead Sciences and Merck Sharp & Dohme. The remaining authors declare that they have no competing interests.
: The study was conducted in accordance with the Declaration of Helsinki (2013) and with the principles of Good Clinical Practice. The study was approved by the Ethics Committee of University of Brescia (Ethics approval number: NP 4364).
: All participants gave a verbal consent prior to the questionnaire administration, participants that gave not the consent were excluded.